|[September 02, 2013]
Research and Markets: Biologicals in Oncology Drug Pipeline Update 2013 Lists all Drugs and Gives you a Progress Analysis on Each One of them
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/wttrrt/biologicals_in)
has announced the addition of the "Biologicals
in Oncology Drug Pipeline Update 2013" report to their offering.
This drug pipeline update covers a wide array of biological drugs, such
as: antibodies,proteins, peptides, DNA, RNA and cellular therapies.
There are today 881 companies plus partners developing 1527 biological
drugs in 3359 developmental projects in cancer. In addition, there are
24 suspended drugs and the accumulated number of ceased drugs over the
last years amount to another 889 drugs.
Identified drugs are linked to 604different targets. All included
targets have been cross-referenced for the presence of mutations
associated with human cancer. To date 566 out of the 570 studied drug
targets so far have been recorded with somatic mutations.
The software application lets you narrow in on these mutations and links
out to the mutational analysis for each of the drug targets for detailed
information. All drugs targets are further categorized on in the
software application by 82 classifications of molecular function and
with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.
Drug Pipeline Update at a Glance
Includes more than 881 principal companies plus their collaborators.
There is direct access from inside the application to web pages of all
This Drug Pipeline Update contains 1527 biological drugs in development,
which have a total of 3359 developmental projects in cancer. In addition
there are suspended and ceased drugs.
For more information visit http://www.researchandmarkets.com/research/wttrrt/biologicals_in
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]